📰 Recommendation Statement News
Page 3 - Recommendation Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recommendation Statement. Real-time updates on events, politics, business and more.
March 11, 2024
Urges Shareholders to Protect Their Investment and the Future of Wyndham by Supporting Only Wyndhams Eight Highly-Qualified Director Nominees Encourages Shareholders to Visit StayWyndham.com for...
February 28, 2024
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
February 13, 2024
Gilead Sciences, Inc. (Nasdaq: GILD) and CymaBay Therapeutics, Inc. (Nasdaq: CBAY) announced today a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the ...
February 6, 2024
Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...
February 6, 2024
Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis intention to submit a voluntary public...
January 30, 2024
As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus...
January 23, 2024
A recent Evidence Report from the US Preventive Services Task Force (USPSTF) highlights a persistent gap in research regarding preventive care services for chil
January 22, 2024
Nominees Selected to Rubber-Stamp Choices Underwhelming and Risk-Laden Offer Board Remains Open to an Offer That is in Best Interests of Wyndham and its Shareholders PARSIPPANY, N.J., Jan. 22,...
January 12, 2024
Extended Regulatory Review Certain Offer Continues to Undervalue Wyndham and Exposes Wyndham Shareholders to Significant Asymmetrical Risk PARSIPPANY, N.J., Jan. 11, 2024 /PRNewswire/ -- Wyndham Hotels & Resorts
January 11, 2024
/PRNewswire/ -- Wyndham Hotels & Resorts (NYSE: WH) ("Wyndham" or the "Company"), the worlds largest hotel franchising company with approximately 9,100 hotels...